Modelling and Simulation

Modelling and Simulation
Product Description

Seda Pharma Development Services provides advanced Modelling & Simulation services to support efficient, data-driven drug product development. Our specialists use physiologically based pharmacokinetic (PBPK) modelling, mechanistic absorption modelling, and simulation tools to predict product performance, assess development risk, and guide formulation and clinical strategies.

Through model-informed approaches, we help clients optimise formulation selection, evaluate bioavailability and bioequivalence risks, reduce development timelines, and make informed decisions before committing to costly experimental studies. Our expertise is particularly valuable for oral solid dosage forms and supports projects from early development through clinical manufacture.

Working closely with pharmaceutical and biotechnology companies, Seda combines modelling expertise with formulation development, analytical sciences, and GMP manufacturing capabilities to deliver in...

Read more Show less

SEDA Pharmaceutical Development Services

  • Country/Region:
    United Kingdom
  • Founded:
    2015
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
Contract Research Organisation
Packaging & drug delivery
View company profile
Categories
more categories Show less
Specifications
  • Details
  • PBPK modelling and simulation
  • Mechanistic absorption modelling
  • Virtual bioequivalence assessments
  • Formulation risk assessment
  • Clinical study design optimisation
  • Dose and formulation selection
  • In vitro-in vivo correlation (IVIVC) support
  • Regulatory submission support
  • Development of oral solid dosage forms
  • Model-informed drug development strategies
  • Selling Points
  • Industry-leading modelling and simulation expertise
  • PBPK and mechanistic modelling capabilities
  • Model-informed drug development approach
  • Supports faster and more confident decision-making
  • Reduces formulation and clinical development risk
  • Integrated with formulation, analytical and GMP manufacturing services
  • Expertise in oral solid dosage forms
  • Strong regulatory and scientific credibility
  • Supplied from
    United Kingdom
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    SEDA Pharmaceutical Development Services

    • Country/Region:
      United Kingdom
    • Founded:
      2015
    • On CPHI since:
      2023
    • Certificates:
      1
    • Employees:
      50 - 99
    Company types
    CMO/CDMO
    Contract Research Organisation (CRO)
    Pharmaceutical company
    Primary activities
    Contract Research Organisation
    Packaging & drug delivery
    View company profile

    More Products from SEDA Pharmaceutical Development Services (5)

    • Analytical Development & Validation Services

      Product Analytical Development & Validation Services

      Seda provides comprehensive Analytical Development and Validation services to support pharmaceutical products from early development through clinical manufacture and regulatory submission.

      Our analytical scientists develop, optimise, validate, and transfer robust analytical methods that ensure p...
    • Clinical Pharmacology services

      Product Clinical Pharmacology services

      Seda  provides expert Clinical Pharmacology services to support informed decision-making from early clinical development through proof-of-concept studies.

      Our team combines clinical pharmacology expertise with advanced modelling and simulation capabilities to evaluate the relationship betwe...
    • Clinical Trial Manufacturing Services

      Product Clinical Trial Manufacturing Services

      Seda  provides GMP Clinical Trial Manufacturing services for pharmaceutical and biotechnology companies progressing products through early-phase clinical development.

      Our experienced manufacturing team delivers high-quality investigational medicinal products (IMPs) for Phase I and Phase II ...
    • Drug Metabolism & Pharmacokinetics (DMPK) Services

      Product Drug Metabolism & Pharmacokinetics (DMPK) Services

      Seda provides comprehensive Drug Metabolism and Pharmacokinetics (DMPK) support to accelerate drug development and inform critical decision-making throughout the product lifecycle.

      Our DMPK scientists combine experimental data with advanced modelling and simulation approaches to characterise abs...
    • Formulation Development

      Product Formulation Development

      Seda provides expert formulation development services that transform promising drug candidates into robust, manufacturable pharmaceutical products. We specialise in OSD forms and support clients from pre-formulation through clinical development & GMP clinical supply manufacture. Our capabilities includ...